Clinical Trials
4 trialsNCT02359565 2026-05-13
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT03294434 2024-09-27
PRaM-GBM
Cambridge University Hospitals NHS Foundation Trust
Completed
NCT00330109 2017-01-16
Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology
AHS Cancer Control Alberta
Phase NA Unknown
NCT01549392 2014-09-15
Imaging Study of Glioblastomas Treated With Avastin
London Health Sciences Centre
Phase NA Terminated